Jin Medical International
ZJYL
ZJYL was delisted on the 31st of July, 2026.
1 hedge funds and large institutions have $178K invested in Jin Medical International in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0.31% more ownership
Funds ownership: 0% → 0.31% (+0.31%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nomura Holdings
Tokyo,
Japan
|
+$186K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Nomura Holdings
Tokyo,
Japan
| $178K | +$186K | +23,956 | New |
|
ZJYL Hedge Fund Activity: Q1 2023 in Review
1 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Jin Medical International (ZJYL) for Q1 2023, worth a combined $178K.
Buyers outnumbered sellers: 1 fund opened new ZJYL positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Nomura Holdings, opening a new position worth an estimated $186K.
- 1 institutional investor held Jin Medical International (ZJYL) as of Q1 2023, up from 0 in Q4 2022.
- Funds reported $178K of Jin Medical International stock for Q1 2023.
- 1 fund opened new Jin Medical International positions in Q1 2023 and 0 closed out, a net change of +1 holder.
- The largest Jin Medical International buyer in Q1 2023 was Nomura Holdings, an estimated $186K added.
Based on aggregated 13F filings for Q1 2023.